Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
21
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| BONDERMAN DAVID | Director | 15 | $3.45M | $0 | 2017-10-03 |
| WITTE OWEN N. | Director | 17 | $0 | $2.51M | 2017-10-03 |
| JENKINSON PAUL L | Chief Financial Officer | 12 | $250.4K | $170.3K | 2017-10-03 |
| MOORE TIMOTHY L. | EVP, Technical Operations | 23 | $0 | $3.34M | 2017-10-03 |
| Tomasello Shawn | Chief Commercial Officer | 13 | $0 | $1.00M | 2017-10-03 |
| Chang David D | EVP, R&D, Chief Medical Off. | 73 | $68.0K | $14.87M | 2017-10-03 |
| Wiezorek Jeffrey | VP Clinical Development | 134 | $68.0K | $10.04M | 2017-10-03 |
| Nussbaum Ran | Director | 35 | $679.5K | $28.62M | 2017-10-03 |
| Ruchefsky Steven B | Director | 16 | $97.3K | $1.79M | 2017-10-03 |
| Humer Franz B | Director | 11 | $0 | $0 | 2017-10-03 |
| Peacock Jonathan M | Director | 13 | $0 | $0 | 2017-10-03 |
| Kim Helen Susan | EVP, Business Development | 77 | $0 | $19.98M | 2017-10-03 |
| CLARK IAN T | Director | 8 | $0 | $0 | 2017-10-03 |
| Belldegrun Arie | Chairman, President and CEO | 30 | $1.17M | $4.91M | 2017-10-03 |
| DOUMANI ROY | Director | 26 | $0 | $3.48M | 2017-10-03 |
| BUTITTA CYNTHIA M | Chief Operating Officer | 163 | $0 | $25.78M | 2017-10-03 |
| Kazam Joshua A | Director | 15 | $0 | $0 | 2017-10-03 |
| CHAMPSI FARAH | Director | 31 | $0 | $64.58M | 2017-10-03 |
| Sproule Rizwana F | VP Regulatory Affairs | 73 | $0 | $6.21M | 2016-03-15 |
| Roberts Margo R | Chief Scientific Officer | 87 | $0 | $6.91M | 2016-03-15 |
| Better Marc | VP, Product Sciences | 63 | $0 | $5.42M | 2016-02-01 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Belldegrun Arie | Chairman, President and CEO | D To issuer deriv | 2017-10-03 | 2017-10-05 | 56,643 | — | $0 | 0 | SEC↗ |
| Belldegrun Arie | Chairman, President and CEO | D To issuer deriv | 2017-10-03 | 2017-10-05 | 159,700 | — | $0 | 0 | SEC↗ |
| Belldegrun Arie | Chairman, President and CEO | D To issuer deriv | 2017-10-03 | 2017-10-05 | 44,057 | $116.13 | $5.12M | 0 | SEC↗ |
| Belldegrun Arie | Chairman, President and CEO | D To issuer deriv | 2017-10-03 | 2017-10-05 | 43,500 | — | $0 | 0 | SEC↗ |
| Belldegrun Arie | Chairman, President and CEO | D To issuer deriv | 2017-10-03 | 2017-10-05 | 95,700 | $128.04 | $12.25M | 0 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | D To issuer deriv | 2017-10-03 | 2017-10-05 | 121,477 | $163.00 | $19.80M | 0 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | D To issuer deriv | 2017-10-03 | 2017-10-05 | 36,284 | — | $0 | 0 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | D To issuer deriv | 2017-10-03 | 2017-10-05 | 44,110 | $178.65 | $7.88M | 0 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | D To issuer deriv | 2017-10-03 | 2017-10-05 | 90,600 | — | $0 | 0 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | D To issuer deriv | 2017-10-03 | 2017-10-05 | 28,034 | — | $0 | 0 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | D To issuer deriv | 2017-10-03 | 2017-10-05 | 51,563 | $128.04 | $6.60M | 0 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | D To issuer deriv | 2017-10-03 | 2017-10-05 | 23,437 | — | $0 | 0 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | D To issuer deriv | 2017-10-03 | 2017-10-05 | 28,919 | $116.13 | $3.36M | 0 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | D To issuer deriv | 2017-10-03 | 2017-10-05 | 37,181 | — | $0 | 0 | SEC↗ |
| Chang David D | EVP, R&D, Chief Medical Off. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 37,181 | — | $0 | 0 | SEC↗ |
| Chang David D | EVP, R&D, Chief Medical Off. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 28,919 | $116.13 | $3.36M | 0 | SEC↗ |
| Chang David D | EVP, R&D, Chief Medical Off. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 23,437 | — | $0 | 0 | SEC↗ |
| Chang David D | EVP, R&D, Chief Medical Off. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 116,750 | $173.11 | $20.21M | 0 | SEC↗ |
| Chang David D | EVP, R&D, Chief Medical Off. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 90,600 | — | $0 | 0 | SEC↗ |
| Chang David D | EVP, R&D, Chief Medical Off. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 56,250 | — | $0 | 0 | SEC↗ |
| Chang David D | EVP, R&D, Chief Medical Off. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 51,563 | $128.04 | $6.60M | 0 | SEC↗ |
| JENKINSON PAUL L | Chief Financial Officer | D To issuer deriv | 2017-10-03 | 2017-10-05 | 83,334 | — | $0 | 0 | SEC↗ |
| JENKINSON PAUL L | Chief Financial Officer | D To issuer deriv | 2017-10-03 | 2017-10-05 | 24,200 | — | $0 | 0 | SEC↗ |
| JENKINSON PAUL L | Chief Financial Officer | D To issuer deriv | 2017-10-03 | 2017-10-05 | 41,666 | $134.96 | $5.62M | 0 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | D To issuer deriv | 2017-10-03 | 2017-10-05 | 52,500 | — | $0 | 0 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | D To issuer deriv | 2017-10-03 | 2017-10-05 | 3,752 | $126.10 | $473.1K | 0 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | D To issuer deriv | 2017-10-03 | 2017-10-05 | 2,499 | $128.57 | $321.3K | 0 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | D To issuer deriv | 2017-10-03 | 2017-10-05 | 35,000 | — | $0 | 0 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | D To issuer deriv | 2017-10-03 | 2017-10-05 | 14,438 | $116.13 | $1.68M | 0 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | D To issuer deriv | 2017-10-03 | 2017-10-05 | 18,562 | — | $0 | 0 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | D To issuer deriv | 2017-10-03 | 2017-10-05 | 38,500 | — | $0 | 0 | SEC↗ |
| Wiezorek Jeffrey | SVP Clinical Development | D To issuer deriv | 2017-10-03 | 2017-10-05 | 38,500 | — | $0 | 0 | SEC↗ |
| Wiezorek Jeffrey | SVP Clinical Development | D To issuer deriv | 2017-10-03 | 2017-10-05 | 14,850 | — | $0 | 0 | SEC↗ |
| Wiezorek Jeffrey | SVP Clinical Development | D To issuer deriv | 2017-10-03 | 2017-10-05 | 11,550 | $116.13 | $1.34M | 0 | SEC↗ |
| Wiezorek Jeffrey | SVP Clinical Development | D To issuer deriv | 2017-10-03 | 2017-10-05 | 11,069 | $128.04 | $1.42M | 0 | SEC↗ |
| Wiezorek Jeffrey | SVP Clinical Development | D To issuer deriv | 2017-10-03 | 2017-10-05 | 29,167 | — | $0 | 0 | SEC↗ |
| Wiezorek Jeffrey | SVP Clinical Development | D To issuer deriv | 2017-10-03 | 2017-10-05 | 28,833 | $173.11 | $4.99M | 0 | SEC↗ |
| Wiezorek Jeffrey | SVP Clinical Development | D To issuer deriv | 2017-10-03 | 2017-10-05 | 5,031 | — | $0 | 0 | SEC↗ |
| Tomasello Shawn | Chief Commercial Officer | D To issuer deriv | 2017-10-03 | 2017-10-05 | 67,000 | — | $0 | 0 | SEC↗ |
| Tomasello Shawn | Chief Commercial Officer | D To issuer deriv | 2017-10-03 | 2017-10-05 | 38,500 | — | $0 | 0 | SEC↗ |
| Tomasello Shawn | Chief Commercial Officer | D To issuer deriv | 2017-10-03 | 2017-10-05 | 93,000 | $116.13 | $10.80M | 0 | SEC↗ |
| MOORE TIMOTHY L. | EVP, Technical Operations | D To issuer deriv | 2017-10-03 | 2017-10-05 | 96,875 | — | $0 | 0 | SEC↗ |
| MOORE TIMOTHY L. | EVP, Technical Operations | D To issuer deriv | 2017-10-03 | 2017-10-05 | 124,125 | $135.09 | $16.77M | 0 | SEC↗ |
| MOORE TIMOTHY L. | EVP, Technical Operations | D To issuer deriv | 2017-10-03 | 2017-10-05 | 30,700 | — | $0 | 0 | SEC↗ |
| WITTE OWEN N. | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 8,810 | $88.79 | $782.2K | 0 | SEC↗ |
| WITTE OWEN N. | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 10,000 | $173.11 | $1.73M | 0 | SEC↗ |
| WITTE OWEN N. | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 30,000 | $124.91 | $3.75M | 0 | SEC↗ |
| WITTE OWEN N. | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 17,130 | $96.11 | $1.65M | 0 | SEC↗ |
| CHAMPSI FARAH | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 50,000 | $178.65 | $8.93M | 0 | SEC↗ |
| CHAMPSI FARAH | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 7,000 | $129.13 | $903.9K | 0 | SEC↗ |
| CHAMPSI FARAH | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 8,810 | $88.79 | $782.2K | 0 | SEC↗ |
| CHAMPSI FARAH | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 10,000 | $120.77 | $1.21M | 0 | SEC↗ |
| Ruchefsky Steven B | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 50,000 | $178.65 | $8.93M | 0 | SEC↗ |
| Ruchefsky Steven B | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 200,000 | $179.30 | $35.86M | 0 | SEC↗ |
| Ruchefsky Steven B | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 8,810 | $88.79 | $782.2K | 0 | SEC↗ |
| Ruchefsky Steven B | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 7,000 | $129.13 | $903.9K | 0 | SEC↗ |
| Ruchefsky Steven B | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 10,000 | $120.77 | $1.21M | 0 | SEC↗ |
| BONDERMAN DAVID | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 50,000 | $178.65 | $8.93M | 0 | SEC↗ |
| BONDERMAN DAVID | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 10,000 | $120.77 | $1.21M | 0 | SEC↗ |
| BONDERMAN DAVID | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 7,000 | $129.13 | $903.9K | 0 | SEC↗ |
| BONDERMAN DAVID | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 8,810 | $88.79 | $782.2K | 0 | SEC↗ |
| DOUMANI ROY | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 8,810 | $88.79 | $782.2K | 0 | SEC↗ |
| DOUMANI ROY | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 30,000 | $173.11 | $5.19M | 0 | SEC↗ |
| DOUMANI ROY | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 10,000 | $120.77 | $1.21M | 0 | SEC↗ |
| DOUMANI ROY | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 7,000 | $129.13 | $903.9K | 0 | SEC↗ |
| Humer Franz B | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 8,810 | $88.79 | $782.2K | 0 | SEC↗ |
| Humer Franz B | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 7,000 | $129.13 | $903.9K | 0 | SEC↗ |
| Humer Franz B | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 20,000 | $123.88 | $2.48M | 0 | SEC↗ |
| Kazam Joshua A | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 50,000 | $178.65 | $8.93M | 0 | SEC↗ |
| Kazam Joshua A | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 10,000 | $120.77 | $1.21M | 0 | SEC↗ |
| Kazam Joshua A | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 7,000 | $129.13 | $903.9K | 0 | SEC↗ |
| Kazam Joshua A | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 8,810 | $88.79 | $782.2K | 0 | SEC↗ |
| Nussbaum Ran | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 50,000 | $178.65 | $8.93M | 0 | SEC↗ |
| Nussbaum Ran | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 7,000 | $129.13 | $903.9K | 0 | SEC↗ |
| Nussbaum Ran | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 10,000 | $120.77 | $1.21M | 0 | SEC↗ |
| Nussbaum Ran | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 8,810 | $88.79 | $782.2K | 0 | SEC↗ |
| CLARK IAN T | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 8,810 | $88.79 | $782.2K | 0 | SEC↗ |
| CLARK IAN T | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 17,130 | $134.05 | $2.30M | 0 | SEC↗ |
| Peacock Jonathan M | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 50,000 | $178.65 | $8.93M | 0 | SEC↗ |
| Peacock Jonathan M | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 10,000 | $120.77 | $1.21M | 0 | SEC↗ |
| Peacock Jonathan M | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 8,810 | $88.79 | $782.2K | 0 | SEC↗ |
| Peacock Jonathan M | Director | D To issuer deriv | 2017-10-03 | 2017-10-05 | 7,000 | $129.13 | $903.9K | 0 | SEC↗ |
| Belldegrun Arie | Chairman, President and CEO | D To issuer | 2017-10-03 | 2017-10-05 | 159,329 | $180.00 | $28.68M | 0 | SEC↗ |
| Belldegrun Arie | Chairman, President and CEO | D To issuer | 2017-10-03 | 2017-10-05 | 500,000 | $180.00 | $90.00M | 0 | SEC↗ |
| Belldegrun Arie | Chairman, President and CEO | D To issuer | 2017-10-03 | 2017-10-05 | 430,190 | $180.00 | $77.43M | 0 | SEC↗ |
| Belldegrun Arie | Chairman, President and CEO | D To issuer | 2017-10-03 | 2017-10-05 | 500,000 | $180.00 | $90.00M | 0 | SEC↗ |
| Belldegrun Arie | Chairman, President and CEO | D To issuer | 2017-10-03 | 2017-10-05 | 1,607,750 | $180.00 | $289.39M | 0 | SEC↗ |
| Belldegrun Arie | Chairman, President and CEO | D To issuer | 2017-10-03 | 2017-10-05 | 159,160 | — | $0 | 0 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | D To issuer | 2017-10-03 | 2017-10-05 | 93,667 | — | $0 | 0 | SEC↗ |
| Chang David D | EVP, R&D, Chief Medical Off. | U Tender | 2017-10-03 | 2017-10-05 | 16,605 | $180.00 | $2.99M | 38,675 | SEC↗ |
| Chang David D | EVP, R&D, Chief Medical Off. | D To issuer | 2017-10-03 | 2017-10-05 | 38,675 | — | $0 | 0 | SEC↗ |
| JENKINSON PAUL L | Chief Financial Officer | D To issuer | 2017-10-03 | 2017-10-05 | 9,462 | — | $0 | 0 | SEC↗ |
| JENKINSON PAUL L | Chief Financial Officer | D To issuer | 2017-10-03 | 2017-10-05 | 3,000 | $180.00 | $540.0K | 0 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | U Tender | 2017-10-03 | 2017-10-05 | 4,193 | $180.00 | $754.7K | 17,500 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | D To issuer | 2017-10-03 | 2017-10-05 | 17,500 | — | $0 | 0 | SEC↗ |
| Wiezorek Jeffrey | SVP Clinical Development | D To issuer | 2017-10-03 | 2017-10-05 | 11,150 | — | $0 | 0 | SEC↗ |
| Wiezorek Jeffrey | SVP Clinical Development | U Tender | 2017-10-03 | 2017-10-05 | 14,674 | $180.00 | $2.64M | 11,150 | SEC↗ |
| Tomasello Shawn | Chief Commercial Officer | U Tender | 2017-10-03 | 2017-10-05 | 16,135 | $180.00 | $2.90M | 39,933 | SEC↗ |
| Tomasello Shawn | Chief Commercial Officer | D To issuer | 2017-10-03 | 2017-10-05 | 39,933 | — | $0 | 0 | SEC↗ |
| MOORE TIMOTHY L. | EVP, Technical Operations | U Tender | 2017-10-03 | 2017-10-05 | 3,927 | $180.00 | $706.9K | 41,734 | SEC↗ |
| MOORE TIMOTHY L. | EVP, Technical Operations | D To issuer | 2017-10-03 | 2017-10-05 | 41,734 | — | $0 | 0 | SEC↗ |
| WITTE OWEN N. | Director | U Tender | 2017-10-03 | 2017-10-05 | 58,535 | $180.00 | $10.54M | 5,715 | SEC↗ |
| WITTE OWEN N. | Director | D To issuer | 2017-10-03 | 2017-10-05 | 5,715 | — | $0 | 0 | SEC↗ |
| CHAMPSI FARAH | Director | U Tender | 2017-10-03 | 2017-10-05 | 61,467 | $180.00 | $11.06M | 1,807 | SEC↗ |
| CHAMPSI FARAH | Director | D To issuer | 2017-10-03 | 2017-10-05 | 1,807 | — | $0 | 0 | SEC↗ |
| Ruchefsky Steven B | Director | D To issuer | 2017-10-03 | 2017-10-05 | 205,586 | — | $0 | 0 | SEC↗ |
| BONDERMAN DAVID | Director | D To issuer | 2017-10-03 | 2017-10-05 | 2,408,084 | — | $0 | 0 | SEC↗ |
| BONDERMAN DAVID | Director | D To issuer | 2017-10-03 | 2017-10-05 | 4,360 | — | $0 | 0 | SEC↗ |
| DOUMANI ROY | Director | D To issuer | 2017-10-03 | 2017-10-05 | 1,807 | — | $0 | 0 | SEC↗ |
| DOUMANI ROY | Director | U Tender | 2017-10-03 | 2017-10-05 | 25,065 | $180.00 | $4.51M | 0 | SEC↗ |
| DOUMANI ROY | Director | U Tender | 2017-10-03 | 2017-10-05 | 150,620 | $180.00 | $27.11M | 1,807 | SEC↗ |
| Humer Franz B | Director | U Tender | 2017-10-03 | 2017-10-05 | 4,624 | $180.00 | $832.3K | 1,807 | SEC↗ |
| Humer Franz B | Director | D To issuer | 2017-10-03 | 2017-10-05 | 1,807 | — | $0 | 0 | SEC↗ |
| Kazam Joshua A | Director | D To issuer | 2017-10-03 | 2017-10-05 | 70,050 | $180.00 | $12.61M | 0 | SEC↗ |
| Kazam Joshua A | Director | U Tender | 2017-10-03 | 2017-10-05 | 2,553 | $180.00 | $459.5K | 1,807 | SEC↗ |
| Kazam Joshua A | Director | D To issuer | 2017-10-03 | 2017-10-05 | 1,807 | — | $0 | 0 | SEC↗ |
| Nussbaum Ran | Director | D To issuer | 2017-10-03 | 2017-10-05 | 2,651 | — | $0 | 0 | SEC↗ |
| Nussbaum Ran | Director | D To issuer | 2017-10-03 | 2017-10-05 | 1,029 | — | $0 | 0 | SEC↗ |
| Nussbaum Ran | Director | D To issuer | 2017-10-03 | 2017-10-05 | 2,632 | — | $0 | 0 | SEC↗ |
| Nussbaum Ran | Director | D To issuer | 2017-10-03 | 2017-10-05 | 3,520 | — | $0 | 0 | SEC↗ |
| Nussbaum Ran | Director | D To issuer | 2017-10-03 | 2017-10-05 | 4,360 | — | $0 | 0 | SEC↗ |
| CLARK IAN T | Director | U Tender | 2017-10-03 | 2017-10-05 | 1,776 | $180.00 | $319.7K | 5,324 | SEC↗ |
| CLARK IAN T | Director | D To issuer | 2017-10-03 | 2017-10-05 | 5,324 | — | $0 | 0 | SEC↗ |
| Peacock Jonathan M | Director | U Tender | 2017-10-03 | 2017-10-05 | 67,932 | $180.00 | $12.23M | 1,807 | SEC↗ |
| Peacock Jonathan M | Director | D To issuer | 2017-10-03 | 2017-10-05 | 1,807 | — | $0 | 0 | SEC↗ |
| CHAMPSI FARAH | Director | G Gift | 2017-09-29 | 2017-10-05 | 2,800 | — | $0 | 63,274 | SEC↗ |
| Kazam Joshua A | Director | J Other | 2017-09-28 | 2017-10-05 | 70,050 | — | $0 | 70,050 | SEC↗ |
| Belldegrun Arie | Chairman, President and CEO | A Award | 2017-09-25 | 2017-10-05 | 50,000 | — | $0 | 159,160 | SEC↗ |
| Tomasello Shawn | Chief Commercial Officer | G Gift | 2017-09-25 | 2017-10-05 | 5,000 | — | $0 | 56,068 | SEC↗ |
| Belldegrun Arie | Chairman, President and CEO | A Award | 2017-09-25 | 2017-09-27 | 50,000 | — | $0 | 135,507 | SEC↗ |
| Belldegrun Arie | Chairman, President and CEO | S Sale | 2017-09-25 | 2017-09-27 | 26,347 | $179.66 | $4.73M | 109,160 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | S Sale | 2017-09-25 | 2017-09-27 | 4,228 | $179.66 | $759.6K | 121,567 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | A Award | 2017-09-25 | 2017-09-27 | 8,000 | — | $0 | 125,795 | SEC↗ |
| JENKINSON PAUL L | Chief Financial Officer | S Sale | 2017-09-25 | 2017-09-27 | 948 | $179.66 | $170.3K | 9,462 | SEC↗ |
| JENKINSON PAUL L | Chief Financial Officer | A Award | 2017-09-25 | 2017-09-27 | 2,500 | — | $0 | 10,410 | SEC↗ |
| Chang David D | EVP, R&D, Chief Medical Off. | A Award | 2017-09-25 | 2017-09-27 | 15,000 | — | $0 | 65,350 | SEC↗ |
| Chang David D | EVP, R&D, Chief Medical Off. | S Sale | 2017-09-25 | 2017-09-27 | 7,927 | $179.66 | $1.42M | 57,423 | SEC↗ |
| Wiezorek Jeffrey | SVP Clinical Development | S Sale | 2017-09-25 | 2017-09-27 | 5,283 | $179.66 | $949.1K | 25,824 | SEC↗ |
| Wiezorek Jeffrey | SVP Clinical Development | A Award | 2017-09-25 | 2017-09-27 | 10,000 | — | $0 | 31,107 | SEC↗ |
| MOORE TIMOTHY L. | EVP, Technical Operations | A Award | 2017-09-25 | 2017-09-27 | 8,000 | — | $0 | 49,889 | SEC↗ |
| MOORE TIMOTHY L. | EVP, Technical Operations | S Sale | 2017-09-25 | 2017-09-27 | 4,228 | $179.66 | $759.6K | 45,661 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | A Award | 2017-09-25 | 2017-09-27 | 6,000 | — | $0 | 24,864 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | S Sale | 2017-09-25 | 2017-09-27 | 3,171 | $179.66 | $569.7K | 21,693 | SEC↗ |
| Tomasello Shawn | Chief Commercial Officer | A Award | 2017-09-25 | 2017-09-27 | 4,500 | — | $0 | 65,271 | SEC↗ |
| Tomasello Shawn | Chief Commercial Officer | S Sale | 2017-09-25 | 2017-09-27 | 4,203 | $179.66 | $755.1K | 61,068 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | G Gift | 2017-09-21 | 2017-10-05 | 27,900 | — | $0 | 93,667 | SEC↗ |
| Chang David D | EVP, R&D, Chief Medical Off. | G Gift | 2017-09-20 | 2017-10-05 | 570 | — | $0 | 55,280 | SEC↗ |
| WITTE OWEN N. | Director | G Gift | 2017-09-18 | 2017-10-05 | 12,000 | — | $0 | 64,250 | SEC↗ |
| Ruchefsky Steven B | Director | G Gift | 2017-09-14 | 2017-10-05 | 2,250 | — | $0 | 205,586 | SEC↗ |
| Chang David D | EVP, R&D, Chief Medical Off. | G Gift | 2017-09-13 | 2017-10-05 | 157 | — | $0 | 55,850 | SEC↗ |
| Peacock Jonathan M | Director | G Gift | 2017-09-13 | 2017-10-05 | 635 | — | $0 | 69,739 | SEC↗ |
| Chang David D | EVP, R&D, Chief Medical Off. | G Gift | 2017-09-12 | 2017-10-05 | 1,041 | — | $0 | 56,007 | SEC↗ |
| Chang David D | EVP, R&D, Chief Medical Off. | G Gift | 2017-09-11 | 2017-10-05 | 375 | — | $0 | 57,048 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | M Exercise deriv | 2017-08-10 | 2017-08-14 | 15,000 | — | $0 | 80,394 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | M Exercise deriv | 2017-08-10 | 2017-08-14 | 2,656 | — | $0 | 37,344 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | M Exercise deriv | 2017-08-10 | 2017-08-14 | 3,595 | — | $0 | 56,407 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | S Sale | 2017-08-10 | 2017-08-14 | 5,800 | $121.03 | $702.0K | 117,795 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | S Sale | 2017-08-10 | 2017-08-14 | 9,200 | $120.52 | $1.11M | 123,595 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | M Exercise | 2017-08-10 | 2017-08-14 | 15,000 | $1.35 | $20.3K | 132,795 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | S Sale | 2017-08-10 | 2017-08-14 | 6,251 | $120.09 | $750.7K | 18,664 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | M Exercise | 2017-08-10 | 2017-08-14 | 2,656 | $51.43 | $136.6K | 24,915 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | M Exercise | 2017-08-10 | 2017-08-14 | 3,595 | $53.90 | $193.8K | 22,259 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | M Exercise deriv | 2017-08-08 | 2017-08-10 | 79,949 | — | $0 | 60,002 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | M Exercise | 2017-08-08 | 2017-08-10 | 79,949 | $53.90 | $4.31M | 98,613 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | S Sale | 2017-08-08 | 2017-08-10 | 1,700 | $117.27 | $199.4K | 85,839 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | S Sale | 2017-08-08 | 2017-08-10 | 3,800 | $118.61 | $450.7K | 82,039 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | S Sale | 2017-08-08 | 2017-08-10 | 18,936 | $119.94 | $2.27M | 63,103 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | S Sale | 2017-08-08 | 2017-08-10 | 31,165 | $120.40 | $3.75M | 31,938 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | S Sale | 2017-08-08 | 2017-08-10 | 13,274 | $121.37 | $1.61M | 18,664 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | S Sale | 2017-08-08 | 2017-08-10 | 11,074 | $115.02 | $1.27M | 87,539 | SEC↗ |
| MOORE TIMOTHY L. | EVP, Technical Operations | M Exercise deriv | 2017-08-03 | 2017-08-04 | 6,000 | — | $0 | 146,000 | SEC↗ |
| MOORE TIMOTHY L. | EVP, Technical Operations | M Exercise | 2017-08-03 | 2017-08-04 | 6,000 | $44.91 | $269.5K | 55,400 | SEC↗ |
| MOORE TIMOTHY L. | EVP, Technical Operations | S Sale | 2017-08-03 | 2017-08-04 | 5,131 | $110.05 | $564.7K | 49,400 | SEC↗ |
| MOORE TIMOTHY L. | EVP, Technical Operations | S Sale | 2017-08-03 | 2017-08-04 | 869 | $110.10 | $95.7K | 54,531 | SEC↗ |
| MOORE TIMOTHY L. | EVP, Technical Operations | M Exercise deriv | 2017-08-01 | 2017-08-03 | 3,000 | — | $0 | 152,000 | SEC↗ |
| MOORE TIMOTHY L. | EVP, Technical Operations | S Sale | 2017-08-01 | 2017-08-03 | 321 | $109.35 | $35.1K | 49,400 | SEC↗ |
| MOORE TIMOTHY L. | EVP, Technical Operations | M Exercise | 2017-08-01 | 2017-08-03 | 3,000 | $44.91 | $134.7K | 61,400 | SEC↗ |
| MOORE TIMOTHY L. | EVP, Technical Operations | S Sale | 2017-08-01 | 2017-08-03 | 2,477 | $106.85 | $264.7K | 58,923 | SEC↗ |
| MOORE TIMOTHY L. | EVP, Technical Operations | S Sale | 2017-08-01 | 2017-08-03 | 5,431 | $107.58 | $584.3K | 53,492 | SEC↗ |
| MOORE TIMOTHY L. | EVP, Technical Operations | S Sale | 2017-08-01 | 2017-08-03 | 3,771 | $108.27 | $408.3K | 49,721 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | M Exercise deriv | 2017-07-31 | 2017-08-01 | 16,550 | — | $0 | 139,951 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | M Exercise deriv | 2017-07-31 | 2017-08-01 | 10,099 | — | $0 | 40,000 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | S Sale | 2017-07-31 | 2017-08-01 | 15,804 | $108.75 | $1.72M | 29,509 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | S Sale | 2017-07-31 | 2017-08-01 | 2,725 | $110.55 | $301.2K | 19,336 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | S Sale | 2017-07-31 | 2017-08-01 | 7,448 | $109.74 | $817.3K | 22,061 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | S Sale | 2017-07-31 | 2017-08-01 | 672 | $111.60 | $75.0K | 18,664 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | M Exercise | 2017-07-31 | 2017-08-01 | 16,550 | $53.90 | $892.0K | 45,313 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | M Exercise | 2017-07-31 | 2017-08-01 | 10,099 | $51.43 | $519.4K | 28,763 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | M Exercise deriv | 2017-07-10 | 2017-07-11 | 15,000 | — | $0 | 95,394 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | S Sale | 2017-07-10 | 2017-07-11 | 5,553 | $102.19 | $567.5K | 123,895 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | S Sale | 2017-07-10 | 2017-07-11 | 5,000 | $105.50 | $527.5K | 117,795 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | M Exercise | 2017-07-10 | 2017-07-11 | 15,000 | $1.35 | $20.3K | 132,795 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | S Sale | 2017-07-10 | 2017-07-11 | 1,100 | $102.81 | $113.1K | 122,795 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | S Sale | 2017-07-10 | 2017-07-11 | 3,347 | $101.06 | $338.2K | 129,448 | SEC↗ |
| Wiezorek Jeffrey | SVP Clinical Development | M Exercise deriv | 2017-07-03 | 2017-07-06 | 10,000 | — | $0 | 58,000 | SEC↗ |
| Wiezorek Jeffrey | SVP Clinical Development | S Sale | 2017-07-03 | 2017-07-06 | 1,201 | $104.76 | $125.8K | 21,071 | SEC↗ |
| Wiezorek Jeffrey | SVP Clinical Development | S Sale | 2017-07-03 | 2017-07-06 | 8,799 | $104.26 | $917.4K | 22,272 | SEC↗ |
| Wiezorek Jeffrey | SVP Clinical Development | M Exercise | 2017-07-03 | 2017-07-06 | 10,000 | $6.89 | $68.9K | 31,071 | SEC↗ |
| WITTE OWEN N. | Director | S Sale | 2017-06-26 | 2017-06-26 | 12,500 | $100.60 | $1.26M | 76,250 | SEC↗ |
| WITTE OWEN N. | Director | M Exercise deriv | 2017-06-23 | 2017-06-26 | 10,000 | — | $0 | 10,000 | SEC↗ |
| WITTE OWEN N. | Director | M Exercise deriv | 2017-06-23 | 2017-06-26 | 2,500 | — | $0 | 0 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | M Exercise deriv | 2017-06-23 | 2017-06-27 | 5,000 | — | $0 | 110,394 | SEC↗ |
| WITTE OWEN N. | Director | M Exercise | 2017-06-23 | 2017-06-26 | 10,000 | $6.89 | $68.9K | 98,750 | SEC↗ |
| WITTE OWEN N. | Director | M Exercise | 2017-06-23 | 2017-06-26 | 2,500 | $62.44 | $156.1K | 101,250 | SEC↗ |
| WITTE OWEN N. | Director | S Sale | 2017-06-23 | 2017-06-26 | 12,500 | $100.00 | $1.25M | 88,750 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | S Sale | 2017-06-23 | 2017-06-27 | 2,050 | $101.19 | $207.4K | 112,795 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | S Sale | 2017-06-23 | 2017-06-27 | 2,950 | $100.54 | $296.6K | 114,845 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | S Sale | 2017-06-23 | 2017-06-27 | 2,050 | $101.19 | $207.4K | 117,795 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | S Sale | 2017-06-23 | 2017-06-27 | 2,950 | $100.54 | $296.6K | 119,845 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | M Exercise | 2017-06-23 | 2017-06-27 | 5,000 | $1.35 | $6.8K | 122,795 | SEC↗ |
| WITTE OWEN N. | Director | A Award deriv | 2017-06-20 | 2017-06-22 | 8,810 | — | $0 | 8,810 | SEC↗ |
| Peacock Jonathan M | Director | A Award deriv | 2017-06-20 | 2017-06-22 | 8,810 | — | $0 | 8,810 | SEC↗ |
| Ruchefsky Steven B | Director | A Award deriv | 2017-06-20 | 2017-06-22 | 8,810 | — | $0 | 8,810 | SEC↗ |
| Nussbaum Ran | Director | A Award deriv | 2017-06-20 | 2017-06-22 | 8,810 | — | $0 | 8,810 | SEC↗ |
| Kazam Joshua A | Director | A Award deriv | 2017-06-20 | 2017-06-22 | 8,810 | — | $0 | 8,810 | SEC↗ |
| Humer Franz B | Director | A Award deriv | 2017-06-20 | 2017-06-22 | 8,810 | — | $0 | 8,810 | SEC↗ |
| DOUMANI ROY | Director | A Award deriv | 2017-06-20 | 2017-06-22 | 8,810 | — | $0 | 8,810 | SEC↗ |
| CLARK IAN T | Director | A Award deriv | 2017-06-20 | 2017-06-22 | 8,810 | — | $0 | 8,810 | SEC↗ |
| BONDERMAN DAVID | Director | A Award deriv | 2017-06-20 | 2017-06-22 | 8,810 | — | $0 | 8,810 | SEC↗ |
| CHAMPSI FARAH | Director | A Award deriv | 2017-06-20 | 2017-06-22 | 8,810 | — | $0 | 8,810 | SEC↗ |
| WITTE OWEN N. | Director | A Award | 2017-06-20 | 2017-06-22 | 2,410 | — | $0 | 88,750 | SEC↗ |
| Peacock Jonathan M | Director | A Award | 2017-06-20 | 2017-06-22 | 2,410 | — | $0 | 70,374 | SEC↗ |
| Ruchefsky Steven B | Director | A Award | 2017-06-20 | 2017-06-22 | 2,410 | — | $0 | 207,836 | SEC↗ |
| Nussbaum Ran | Director | A Award | 2017-06-20 | 2017-06-22 | 2,410 | — | $0 | 4,360 | SEC↗ |
| Kazam Joshua A | Director | A Award | 2017-06-20 | 2017-06-22 | 2,410 | — | $0 | 4,360 | SEC↗ |
| Humer Franz B | Director | A Award | 2017-06-20 | 2017-06-22 | 2,410 | — | $0 | 6,431 | SEC↗ |
| DOUMANI ROY | Director | A Award | 2017-06-20 | 2017-06-22 | 2,410 | — | $0 | 152,427 | SEC↗ |
| CLARK IAN T | Director | A Award | 2017-06-20 | 2017-06-22 | 2,410 | — | $0 | 7,100 | SEC↗ |
| BONDERMAN DAVID | Director | A Award | 2017-06-20 | 2017-06-22 | 2,410 | — | $0 | 4,360 | SEC↗ |
| CHAMPSI FARAH | Director | A Award | 2017-06-20 | 2017-06-22 | 2,410 | — | $0 | 66,074 | SEC↗ |
| CHAMPSI FARAH | Director | S Sale | 2017-06-16 | 2017-06-16 | 5,450 | $88.11 | $480.2K | 0 | SEC↗ |
| CHAMPSI FARAH | Director | S Sale | 2017-06-14 | 2017-06-16 | 15,000 | $90.40 | $1.36M | 63,664 | SEC↗ |
| Ruchefsky Steven B | Director | S Sale | 2017-06-14 | 2017-06-16 | 20,000 | $89.48 | $1.79M | 205,426 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | M Exercise deriv | 2017-06-09 | 2017-06-12 | 10,000 | — | $0 | 115,394 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | S Sale | 2017-06-09 | 2017-06-12 | 1,698 | $89.76 | $152.4K | 118,195 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | S Sale | 2017-06-09 | 2017-06-12 | 400 | $91.08 | $36.4K | 117,795 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | S Sale | 2017-06-09 | 2017-06-12 | 4,100 | $89.09 | $365.3K | 119,893 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | S Sale | 2017-06-09 | 2017-06-12 | 2,502 | $87.80 | $219.7K | 123,993 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | S Sale | 2017-06-09 | 2017-06-12 | 900 | $86.42 | $77.8K | 126,495 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | S Sale | 2017-06-09 | 2017-06-12 | 400 | $84.81 | $33.9K | 127,395 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | M Exercise | 2017-06-09 | 2017-06-12 | 10,000 | $1.35 | $13.5K | 127,795 | SEC↗ |
| DOUMANI ROY | Director | S Sale | 2017-06-08 | 2017-06-09 | 5,000 | $84.53 | $422.6K | 150,017 | SEC↗ |
| DOUMANI ROY | Director | S Sale | 2017-06-07 | 2017-06-09 | 10,000 | $84.46 | $844.6K | 155,017 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | M Exercise deriv | 2017-06-01 | 2017-06-05 | 2,400 | — | $0 | 50,099 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | M Exercise | 2017-06-01 | 2017-06-05 | 2,400 | $51.43 | $123.4K | 21,064 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | S Sale | 2017-06-01 | 2017-06-05 | 2,400 | $72.45 | $173.9K | 18,664 | SEC↗ |
| JENKINSON PAUL L | Chief Financial Officer | P Buy | 2017-05-10 | 2017-05-10 | 450 | $72.57 | $32.7K | 7,480 | SEC↗ |
| JENKINSON PAUL L | Chief Financial Officer | P Buy | 2017-05-10 | 2017-05-10 | 3,000 | $72.59 | $217.8K | 3,000 | SEC↗ |
| Belldegrun Arie | Chairman, President and CEO | P Buy | 2017-05-09 | 2017-05-09 | 17,000 | $68.57 | $1.17M | 85,507 | SEC↗ |
| BONDERMAN DAVID | Director | P Buy | 2017-05-09 | 2017-05-09 | 46,185 | $68.84 | $3.18M | 2,404,269 | SEC↗ |
| BONDERMAN DAVID | Director | P Buy | 2017-05-09 | 2017-05-09 | 3,815 | $70.15 | $267.6K | 2,408,084 | SEC↗ |
| Ruchefsky Steven B | Director | P Buy | 2017-05-09 | 2017-05-10 | 1,400 | $69.50 | $97.3K | 225,426 | SEC↗ |
| Nussbaum Ran | Director | P Buy | 2017-05-09 | 2017-05-11 | 1,029 | $69.17 | $71.2K | 1,029 | SEC↗ |
| Nussbaum Ran | Director | P Buy | 2017-05-09 | 2017-05-11 | 2,651 | $69.17 | $183.4K | 2,651 | SEC↗ |
| Nussbaum Ran | Director | P Buy | 2017-05-09 | 2017-05-11 | 3,520 | $69.17 | $243.5K | 3,520 | SEC↗ |
| Nussbaum Ran | Director | P Buy | 2017-05-09 | 2017-05-11 | 2,632 | $68.94 | $181.5K | 2,632 | SEC↗ |
| Chang David D | EVP, R&D, Chief Medical Off. | M Exercise deriv | 2017-05-01 | 2017-05-03 | 20,000 | — | $0 | 123,000 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | M Exercise deriv | 2017-05-01 | 2017-05-03 | 2,400 | — | $0 | 156,501 | SEC↗ |
| Chang David D | EVP, R&D, Chief Medical Off. | S Sale | 2017-05-01 | 2017-05-03 | 300 | $83.36 | $25.0K | 50,165 | SEC↗ |
| Chang David D | EVP, R&D, Chief Medical Off. | S Sale | 2017-05-01 | 2017-05-03 | 5,905 | $82.60 | $487.8K | 50,465 | SEC↗ |
| Chang David D | EVP, R&D, Chief Medical Off. | S Sale | 2017-05-01 | 2017-05-03 | 13,795 | $81.84 | $1.13M | 56,370 | SEC↗ |
| Chang David D | EVP, R&D, Chief Medical Off. | M Exercise | 2017-05-01 | 2017-05-03 | 20,000 | $6.89 | $137.8K | 70,165 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | M Exercise | 2017-05-01 | 2017-05-03 | 2,400 | $53.90 | $129.4K | 21,064 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | S Sale | 2017-05-01 | 2017-05-03 | 2,400 | $82.12 | $197.1K | 18,664 | SEC↗ |
| CHAMPSI FARAH | Director | S Sale | 2017-04-28 | 2017-05-01 | 2,617 | $82.59 | $216.1K | 4,962 | SEC↗ |
| CHAMPSI FARAH | Director | S Sale | 2017-04-27 | 2017-05-01 | 16,551 | $82.77 | $1.37M | 7,579 | SEC↗ |
| CHAMPSI FARAH | Director | S Sale | 2017-04-26 | 2017-04-26 | 51,112 | $82.72 | $4.23M | 24,330 | SEC↗ |
| CHAMPSI FARAH | Director | S Sale | 2017-04-26 | 2017-04-26 | 200 | $83.06 | $16.6K | 24,130 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | M Exercise deriv | 2017-04-25 | 2017-04-27 | 15,000 | — | $0 | 125,394 | SEC↗ |
| CHAMPSI FARAH | Director | S Sale | 2017-04-25 | 2017-04-26 | 15,316 | $83.29 | $1.28M | 75,442 | SEC↗ |
| CHAMPSI FARAH | Director | S Sale | 2017-04-25 | 2017-04-26 | 31,467 | $82.56 | $2.60M | 90,758 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | S Sale | 2017-04-25 | 2017-04-27 | 3,742 | $82.87 | $310.1K | 117,795 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | S Sale | 2017-04-25 | 2017-04-27 | 5,545 | $82.14 | $455.5K | 121,537 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | S Sale | 2017-04-25 | 2017-04-27 | 5,713 | $80.89 | $462.1K | 127,082 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | M Exercise | 2017-04-25 | 2017-04-27 | 15,000 | $1.35 | $20.3K | 132,795 | SEC↗ |
| CHAMPSI FARAH | Director | S Sale | 2017-04-24 | 2017-04-26 | 25,818 | $82.34 | $2.13M | 122,225 | SEC↗ |
| CHAMPSI FARAH | Director | S Sale | 2017-04-17 | 2017-04-17 | 100 | $83.06 | $8.3K | 148,043 | SEC↗ |
| CHAMPSI FARAH | Director | S Sale | 2017-04-17 | 2017-04-17 | 43,001 | $82.48 | $3.55M | 148,143 | SEC↗ |
| CHAMPSI FARAH | Director | S Sale | 2017-04-13 | 2017-04-17 | 72,275 | $82.39 | $5.95M | 191,144 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | M Exercise deriv | 2017-04-03 | 2017-04-04 | 5,000 | — | $0 | 140,394 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | M Exercise deriv | 2017-04-03 | 2017-04-04 | 2,400 | — | $0 | 158,901 | SEC↗ |
| Chang David D | EVP, R&D, Chief Medical Off. | M Exercise deriv | 2017-04-03 | 2017-04-04 | 20,000 | — | $0 | 143,000 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | S Sale | 2017-04-03 | 2017-04-04 | 2,400 | $82.38 | $197.7K | 118,595 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | S Sale | 2017-04-03 | 2017-04-04 | 1,800 | $80.69 | $145.2K | 120,995 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | M Exercise | 2017-04-03 | 2017-04-04 | 5,000 | $1.35 | $6.8K | 122,795 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | S Sale | 2017-04-03 | 2017-04-04 | 100 | $84.22 | $8.4K | 117,795 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | S Sale | 2017-04-03 | 2017-04-04 | 700 | $83.46 | $58.4K | 117,895 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | M Exercise | 2017-04-03 | 2017-04-04 | 2,400 | $53.90 | $129.4K | 21,064 | SEC↗ |
| Kim Helen Susan | EVP, Business Development | S Sale | 2017-04-03 | 2017-04-04 | 2,400 | $81.80 | $196.3K | 18,664 | SEC↗ |
| Chang David D | EVP, R&D, Chief Medical Off. | S Sale | 2017-04-03 | 2017-04-04 | 3,549 | $82.00 | $291.0K | 59,562 | SEC↗ |
| Chang David D | EVP, R&D, Chief Medical Off. | S Sale | 2017-04-03 | 2017-04-04 | 8,697 | $82.60 | $718.4K | 50,865 | SEC↗ |
| Chang David D | EVP, R&D, Chief Medical Off. | S Sale | 2017-04-03 | 2017-04-04 | 700 | $83.66 | $58.6K | 50,165 | SEC↗ |
| Chang David D | EVP, R&D, Chief Medical Off. | M Exercise | 2017-04-03 | 2017-04-04 | 20,000 | $6.89 | $137.8K | 70,165 | SEC↗ |
| Chang David D | EVP, R&D, Chief Medical Off. | S Sale | 2017-04-03 | 2017-04-04 | 3,939 | $79.63 | $313.7K | 65,535 | SEC↗ |
| Chang David D | EVP, R&D, Chief Medical Off. | S Sale | 2017-04-03 | 2017-04-04 | 2,424 | $80.44 | $195.0K | 63,111 | SEC↗ |
| Chang David D | EVP, R&D, Chief Medical Off. | S Sale | 2017-04-03 | 2017-04-04 | 691 | $78.53 | $54.3K | 69,474 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | M Exercise deriv | 2017-03-27 | 2017-03-28 | 10,000 | — | $0 | 145,394 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | M Exercise | 2017-03-27 | 2017-03-28 | 10,000 | $1.35 | $13.5K | 127,795 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | S Sale | 2017-03-27 | 2017-03-28 | 300 | $75.74 | $22.7K | 127,495 | SEC↗ |
| BUTITTA CYNTHIA M | Chief Operating Officer | S Sale | 2017-03-27 | 2017-03-28 | 4,375 | $77.23 | $337.9K | 123,120 | SEC↗ |